CR3 is the dominant phagocytotic complement receptor on human dendritic cells

Immunobiology

Volumn 218, Issue 4, 2013, Pages 652-663

  Sándor, Noémi ^a   Kristóf, Katalin ^a   Paréj, Katalin ^a,b   Pap, Domonkos ^a   Erdei, Anna ^a   Bajtay, Zsuzsa ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b INSTITUTE OF ENZYMOLOGY   (Hungary)

Author keywords

2 Integrins; CD11b CD18; CD11c CD18; Complement C3; Human dendritic cell; Phagocytosis

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR CR2; COMPLEMENT RECEPTOR CR3; COMPLEMENT RECEPTOR CR4; GLYCOPROTEIN P 15095; INTERLEUKIN 6; INTERLEUKIN 8; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; LIGAND BINDING; MONOCYTE DERIVED DENDRITIC CELL; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION;

CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INTEGRIN ALPHAXBETA2; MACROPHAGE-1 ANTIGEN; MALE; MONOCYTES; PHAGOCYTOSIS;

EID: 84875259319     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.07.031     Document Type: Article

References (51)

1. Abram C.L., Lowell C.A. The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 2009, 27:339-362.
2. Bajtay Z., Csomor E., Sandor N., Erdei A. Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol. Lett. 2006, 104:46-52.
3. Bajtay Z., Speth C., Erdei A., Dierich M.P. Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3 CD11b/CD18). J. Immunol. 2004, 173:4775-4778.
4. Behrens E.M., Sriram U., Shivers D.K., Gallucci M., Ma Z., Finkel T.H., Gallucci S. Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J. Immunol. 2007, 178:6268-6279.
5. Berton G., Lowell C.A. Integrin signalling in neutrophils and macrophages. Cell Signal 1999, 11:621-635.
6. Birdsall H.H., Porter W.J., Trial J., Rossen R.D. Monocytes stimulated by 110-kDa fibronectin fragments suppress proliferation of anti-CD3-activated T cells. J. Immunol. 2005, 175:3347-3353.
7. 1 or LFA-1. EMBO J. 1992, 11(2):405-410.
8. Bunting M., Harris E.S., McIntyre T.M., Prescott S.M., Zimmerman G.A. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr. Opin. Hematol. 2002, 9:30-35.
9. Capron A., Dessaint J.P. Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view. Annu. Rev. Immunol. 1985, 3:455-476.
10. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 1998, 16:545-568.
11. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5:981-986.
12. Dupuy A.G., Caron E. Integrin-dependent phagocytosis: spreading from microadhesion to new concepts. J. Cell Sci. 2008, 121:1773-1783.
13. Ehirchiou D., Xiong Y., Xu G., Chen W., Shi Y., Zhang L. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J. Exp. Med. 2007, 204:1519-1524.
14. Erdei A., Isaak A., Torok K., Sandor N., Kremlitzka M., Prechl J., Bajtay Z. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. Mol. Immunol. 2009, 46:2767-2773.
15. Erdei A., Kohler V., Schafer H., Burger R. Macrophage-bound C3 fragments as adhesion molecules modulate presentation of exogenous antigens. Immunobiology 1992, 185:314-326.
16. Fabry Z., Erdei A., Gergely J. A possible self-regulating mechanism mediated by C3b-acceptor-bound C3b generated by stimulated macrophages. Scand. J. Immunol. 1985, 22:549-555.
17. Gelderman K.A., Kuppen P.J., Okada N., Fleuren G.J., Gorter A. Tumor-specific inhibition of membrane-bound complement regulatory protein Crry with bispecific monoclonal antibodies prevents tumor outgrowth in a rat colorectal cancer lung metastases model. Cancer Res. 2004, 64:4366-4372.
18. Gelderman K.A., Tomlinson S., Ross G.D., Gorter A. Complement function in mAb-mediated cancer immunotherapy. Trends Immunol. 2004, 25:158-164.
19. Georgakopoulos T., Moss S.T., Kanagasundaram V. Integrin CD11c contributes to monocyte adhesion with CD11b in a differential manner and requires Src family kinase activity. Mol. Immunol. 2008, 45:3671-3681.
20. Gergely J., Bajtay Z., Erdei A., Fabry Z. Functional cooperation of C3b-acceptors, Fc gamma-receptors and cell-surface proteases on macrophages. Immunol. Lett. 1985, 11:141-146.
21. Graham I.L., Gresham H.D., Brown E.J. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors. J. Immunol. 1989, 142:2352-2358.
22. Gresham H.D., Graham I.L., Anderson D.C., Brown E.J. Leukocyte adhesion-deficient neutrophils fail to amplify phagocytic function in response to stimulation. Evidence for CD11b/CD18-dependent and -independent mechanisms of phagocytosis. J. Clin. Invest. 1991, 88:588-597.
23. Kacani L., Frank I., Spruth M., Schwendinger M.G., Mullauer B., Sprinzl G.M., Steindl F., Dierich M.P. Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. J. Virol. 1998, 72:6671-6677.
24. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
25. Kerekes K., Prechl J., Bajtay Z., Jozsi M., Erdei A. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int. Immunol. 1998, 10:1923-1930.
26. Li K., Fazekasova H., Wang N., Sagoo P., Peng Q., Khamri W., Gomes C., Sacks S.H., Lombardi G., Zhou W. Expression of complement components, receptors and regulators by human dendritic cells. Mol. Immunol. 2011, 48:1121-1127.
27. Liu D., Niu Z.X. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35). Immunopharmacol. Immunotoxicol. 2009, 31:524-535.
28. MacPherson M., Lek H.S., Prescott A., Fagerholm S.C. A systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis. J. Biol. Chem. 2011, 286:17303-17310.
29. Maison C.M., Villiers C.L., Colomb M.G. Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937. Biochem. J. 1989, 261:407-413.
30. Morelli A.E., Larregina A.T., Shufesky W.J., Zahorchak A.F., Logar A.J., Papworth G.D., Wang Z., Watkins S.C., Falo L.D., Thomson A.W. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003, 101:611-620.
31. Nauta A.J., Castellano G., Xu W., Woltman A.M., Borrias M.C., Daha M.R., van Kooten C., Roos A. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J. Immunol. 2004, 173:3044-3050.
32. Nauta A.J., Trouw L.A., Daha M.R., Tijsma O., Nieuwland R., Schwaeble W.J., Gingras A.R., Mantovani A., Hack E.C., Roos A. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 2002, 32:1726-1736.
33. Oliva C.R., Swiecki M.K., Griguer C.E., Lisanby M.W., Bullard D.C., Turnbough C.L., Kearney J.F. The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1261-1266.
34. Papp K., Vegh P., Prechl J., Kerekes K., Kovacs J., Csikos G., Bajtay Z., Erdei A. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity. Mol. Immunol. 2008, 45:2343-2351.
35. Pickl W.F., Majdic O., Kohl P., Stockl J., Riedl E., Scheinecker C., Bello-Fernandez C., Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 1996, 157:3850-3859.
36. Prechtel A.T., Turza N.M., Theodoridis A.A., Steinkasserer A. CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J. Immunol. 2007, 178:5454-5464.
37. Rosen H., Law S.K. The leukocyte cell surface receptor(s) for the iC3b product of complement. Curr. Top. Microbiol. Immunol. 1990, 153:99-122.
38. Ross G.D., Vetvicka V. CR3 (CD11b CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 1993, 92:181-184.
39. Sandor N., Pap D., Prechl J., Erdei A., Bajtay Z. A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes. Mol. Immunol. 2009, 47:438-448.
40. Schmidt J., Klempp C., Buchler M.W., Marten A. Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo. Cancer Immunol. Immunother. 2006, 55:31-38.
41. Skoberne M., Somersan S., Almodovar W., Truong T., Petrova K., Henson P.M., Bhardwaj N. The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood 2006, 108:947-955.
42. Sohn J.H., Bora P.S., Suk H.J., Molina H., Kaplan H.J., Bora N.S. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat. Med. 2003, 9:206-212.
43. Turner M.W., Grant C., Seymour N.D., Harvey B., Levinsky R.J. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential. Immunology 1986, 58:111-115.
44. Török K., Kremlitzka M., Sándor N., Tóth E.A., Bajtay Zs., Erdei A. Human T cell derived, cell-bound complement iC3b is integrally involved in T cell activation. Immunol. Lett. 2012, 143:131-136.
45. van Spriel A.B., Leusen J.H., van Egmond M., Dijkman H.B., Assmann K.J., Mayadas T.N., van de Winkel J.G. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood 2001, 97:2478-2486.
46. van Spriel A.B., van Ojik H.H., Bakker A., Jansen M.J., van de Winkel J.G. Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma. Blood 2003, 101:253-258.
47. Varga G., Balkow S., Wild M.K., Stadtbaeumer A., Krummen M., Rothoeft T., Higuchi T., Beissert S., Wethmar K., Scharffetter-Kochanek K., Vestweber D., Grabbe S. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood 2007, 109:661-669.
48. Veldhoen M. Oral tolerance: passing CD11b on the way to tolerance. Immunol. Cell Biol. 2007, 85:397-398.
49. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben-Tal O., Kutikov I., Gill O., Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 2002, 196:1553-1561.
50. Vignali D.A., Bickle Q.D., Crocker P., Taylor M.G. Antibody-dependent killing of Schistosoma mansoni schistosomula in vitro by starch-elicited murine macrophages. Critical role of the cell surface integrin Mac-1 in killing mediated by the anti-Mr 16,000mAb B3A. J. Immunol. 1990, 144:4030-4037.
51. Wagner C., Hansch G.M., Stegmaier S., Denefleh B., Hug F., Schoels M. The complement receptor 3 CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur. J. Immunol. 2001, 31:1173-1180.